DANIEL LYNCH Insider Trading $IMCLE IMCLONE SYSTEMS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DANIEL LYNCH.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DANIEL LYNCH. DANIEL LYNCH is Acting Chief Executive Officer in IMCLONE SYSTEMS INC ($IMCLE) and Chief Executive Officer in IMCLONE SYSTEMS INC ($IMCLE) and in bluebird bio, Inc. ($BLUE) and Director in bluebird bio, Inc. ($BLUE) and Director in BIND Therapeutics, Inc ($BIND) and Director in Eleven Biotherapeutics, Inc. ($EBIO) and Director in Blueprint Medicines Corp ($BPMC) and Director in Translate Bio, Inc. ($TBIO) and Director in Surface Oncology, Inc. ($SURF) and Director in SpringWorks Therapeutics, Inc. ($SWTX).

DANIEL LYNCH in IMCLONE SYSTEMS INC

Trading Symbol: IMCLE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH: Acting Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Dec 22 2004

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DANIEL LYNCH in IMCLONE SYSTEMS INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BLUE, BPMC, BIND, IMCLE, SESN, SWTX, SURF, TBIO

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Dec 22 2004	IMCLE	IMCLONE SYSTEMS IN ...	LYNCH DANIEL	Chief Executive Off ...	Option Exercise	A	44.24	32,500	1,437,800	32,500
Mar 23 2004	IMCLE	IMCLONE SYSTEMS IN ...	LYNCH DANIEL	Chief Executive Off ...	Option Exercise	A	48.07	250,000	12,017,500	250,000
Dec 24 2003	IMCLE	IMCLONE SYSTEMS IN ...	LYNCH DANIEL	Acting Chief Execut ...	Option Exercise	A	39.79	32,500	1,293,175	32,500

Page: 1